Caption Management’s 89bio ETNB Stock Holding History

Caption Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$393K	–	1775
2025 Q2	$393K	Sell	40,000 -35,000	-47%	-$290K	﹤0.01%	1166
2025 Q1	$545K	Buy	+75,000	New	+$656K	0.01%	1081
2024 Q2	–	Sell	-86,000	Closed	-$1M	–	1264
2024 Q1	$1M	Buy	+86,000	New	+$952K	0.02%	733
2023 Q4	–	Sell	-120,000	Closed	-$1.85M	–	1428
2023 Q3	$1.85M	Buy	+120,000	New	+$2.01M	0.03%	600
2023 Q2	–	Sell	-1,699,100	Closed	-$25.9M	–	1186
2023 Q1	$25.9M	Buy	+1,699,100	New	+$22.2M	0.5%	46

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's ETNB Position: Q4 2025 in Review

Caption Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 196,300 shares — an estimated $2.89M sold.

Caption Management first reported a position in ETNB in Q1 2023 and held it in 10 quarters. The position peaked at $3.97M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Caption Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Caption Management sold 196,300 89bio shares in Q4 2025, an estimated $2.89M.
Caption Management first reported a position in 89bio in Q1 2023 and held it in 10 quarters.
Caption Management's 89bio position peaked at $3.97M in Q1 2023.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.